Data set accession numbers | GeneChip models | Databases | Availability | Experimental conditions |
---|---|---|---|---|
E-GEOD-1323 | HG-U133A | AE | Available | 3 human colorectal cancer derived from a primary tumor VS. 3 corresponding lymph node metastases |
E-GEOD-2280 | HG-U133A | AE | Available | 8 squamous cell carcinoma of the oral cavity VS. 19 corresponding lymph node metastases |
E-MEXP-44 | HG-U95Av2 | AE | Available | 15 head and neck squamous cell carcinoma VS. 3 corresponding lymph node metastases |
 | HG-UgeneFL | AE | Available | 12 head and neck squamous cell carcinoma VS. 11 corresponding lymph node metastases |
GSE1056 | HG-U95Av2 | GEO | Not available | 2 human hepatocellular carcinoma under hypoxia for 2 hours VS. 2 control human hepatocellular carcinoma |
 | HG-U95Av2 | GEO | Not available | 2 human hepatocellular carcinoma under hypoxia for 24 hours VS. 2 control human hepatocellular carcinoma |
GSE2280 | HG-U133A | GEO | Available | 22 squamous cell carcinoma of the oral cavity VS. 5 corresponding lymph node metastases |
GSE2603 | HG-U133A | GEO | Available | 100 primary breast cancer VS. 21 lung metastases |
GSE3325 | HG-U133Plus2.0 | GEO | Available | 7 primary prostate cancer VS. 6 metastases |
GSE4086 | HG-U133Plus2.0 | GEO | Available | 2 human Burkitt's lymphoma under hypoxia VS. 2 control human Burkitt's lymphoma |
GSE468 | HC-G110 | GEO | Available | 13 primary medulloblastomas VS. 10 metastatic medulloblastomas |
GSE4840 | HG-U133A | GEO | Not available | 3 samples from normal melanocyte culture VS. 12 samples from culture of cutaneous metastasis of melanoma |
 | HG-U133B | GEO | Not available | 3 samples from normal melanocyte culture VS. 12 samples from culture of cutaneous metastasis of melanoma |
GSE4843 | HG-U133Plus2.0 | GEO | Not available | 45 samples from culture of cutaneous melanoma metastasis |
GSE6369 | HG-U133Plus2.0 | GEO | Available | 1 primary prostate carcinoma VS. 1 metastatic prostate carcinoma |
GSE6919 | HG-U95Av2 | GEO | Available | 65 primary prostate tumors VS. 25 metastatic prostate tumors |
 | HG-U95B | GEO | Available | 66 primary prostate tumors VS. 25 metastatic prostate tumors |
 | HG-U95C | GEO | Available | 65 primary prostate tumors VS. 25 metastatic prostate tumors |
GSE7929 | HG-U133A | GEO | Available | 11 poorly metastatic melanoma VS. 21 highly metastatic melanoma |
GSE7930 | HG-U133A | GEO | Available | 3 poorly metastatic prostate tumors VS. 3 highly metastatic prostate tumors |
GSE7956 | HG-U133A | GEO | Available | 10 poorly metastatic melanoma VS. 29 highly metastatic melanoma |
GSE8401 | HG-U133A | GEO | Available | 31 primary melanoma VS. 52 melanoma metastasis |